Canada Life
ONC

Canada Life’s BeOne Medicines Ltd ONC Stock Holding History

Canada Life’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-17,252
Closed -$3.88M – 2070
2024
Q3 		$3.88M Buy
17,252
+234
+1% +$42.1K 0.01% 998
2024
Q2 		$2.43M Sell
17,018
-11,286
-40% -$1.74M ﹤0.01% 1187
2024
Q1 		$4.42M Buy
28,304
+1,282
+5% +$206K 0.01% 869
2023
Q4 		$4.84M Sell
27,022
-297,694
-92% -$53.9M 0.01% 790
2023
Q3 		$8.33M Buy
324,716
+273,087
+529% +$54M 0.02% 565
2023
Q2 		$9.23M Sell
51,629
-1,377
-3% -$317K 0.02% 537
2023
Q1 		$11.4M Sell
53,006
-28,600
-35% -$6.86M 0.03% 494
2022
Q4 		$18M Buy
81,606
+11,800
+17% +$2.16M 0.05% 386
2022
Q3 		$9.4M Buy
69,806
+2,700
+4% +$464K 0.03% 519
2022
Q2 		$10.9M Sell
67,106
-1,100
-2% -$172K 0.03% 511
2022
Q1 		$13.4M Buy
68,206
+5,800
+9% +$1.23M 0.03% 502
2021
Q4 		$16.8M Sell
62,406
-3,094
-5% -$1.04M 0.03% 454
2021
Q3 		$23.9M Buy
65,500
+7,200
+12% +$2.35M 0.06% 359
2021
Q2 		$20M Buy
58,300
+7,200
+14% +$2.38M 0.05% 397
2021
Q1 		$17.7M Buy
51,100
+4,200
+9% +$1.39M 0.04% 413
2020
Q4 		$12.1M Buy
46,900
+27,000
+136% +$7.43M 0.02% 554
2020
Q3 		$5.69M Buy
19,900
+1,200
+6% +$282K 0.01% 671
2020
Q2 		$3.51M Sell
18,700
-1,200
-6% -$195K 0.01% 817
2020
Q1 		$2.47M Buy
19,900
+100
+0.5% +$15.6K 0.01% 859
2019
Q4 		$3.26M Sell
19,800
-2,700
-12% -$449K 0.01% 878
2019
Q3 		$2.76M Buy
22,500
+2,100
+10% +$279K 0.01% 780
2019
Q2 		$2.52M Buy
20,400
+3,949
+24% +$501K 0.01% 1031
2019
Q1 		$2.17M Buy
16,451
+7,500
+84% +$1.01M 0.01% 1004
2018
Q4 		$1.21M Buy
+8,951
New +$1.19M ﹤0.01% 1314

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Canada Life's ONC Position: Q4 2024 in Review

Canada Life sold out of BeOne Medicines Ltd (ONC) in Q4 2024, closing a stake of 17,252 shares — an estimated $3.88M sold.

Canada Life first reported a position in ONC in Q4 2018 and held it in 24 quarters. The position peaked at $23.9M in Q3 2021. 227 funds tracked by Wall St. Rank hold ONC as of Q4 2024.

  • Canada Life reported no remaining BeOne Medicines Ltd position as of Q4 2024 after selling out during the quarter.
  • Canada Life sold 17,252 BeOne Medicines Ltd shares in Q4 2024, an estimated $3.88M.
  • Canada Life first reported a position in BeOne Medicines Ltd in Q4 2018 and held it in 24 quarters.
  • Canada Life's BeOne Medicines Ltd position peaked at $23.9M in Q3 2021.
  • 227 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2024.

Based on Canada Life's 13F filing for Q4 2024, filed 13 Feb 2025.